Venue

This year's event will be held in Boston, MA at the Revere Hotel Boston Common.

Boston Revere Hotel
Boston Revere Hotel
Boston Revere Hotel

Dedicated Room Block

We are pleased to announce that for 2nd Proteomic Based Drug Discovery Summit 2026, we have a dedicated room block at the conference hotel, Revere Hotel Boston Common

We have a discounted nightly room rate of $139++ from Monday 2nd February to Thursday 5th February

The booking reservation contact number is: 1-413-821-3830  please  refer to ‘2nd Proteomic Based Drug Discovery Summit 2026’ if you are calling in.

Reservations must be made by Friday January 16 which is the cutoff date. However, please note due to high demand, rooms may sell out before the cutoff date so we do recommend you book your accommodation sooner rather than later.

Please email Cate Tupper at cate.tupper@hansonwade.com if you have any questions or queries regarding the room block.

Superior-Deluxe-and-premier-king-scaled-1.jpg

Warning: Unsolicited Accommodation Calls/Emails to Hanson Wade Group Attendees

It has been brought to our attention that there are multiple third-party companies contacting our conference attendees claiming to represent Hanson Wade and/or one of our conference brands with fraudulent hotel booking schemes. Please review our accommodation policy here for the full details: Accommodation Policy - Hanson Wade Group.

Explore The Agenda
Explore the Agenda

Hear the latest breakthroughs in throughput, coverage, and sensitivity of proteomics methodologies, uncover data-driven presentations, and engage in panel discussions on translating large-scale proteomics data into meaningful drug discovery conclusions.

Partner with Us
Partner With Us

Position yourself alongside other proteomics, mass spectrometry and data analysis solution providers, demonstrating your capabilities and increasing your brand awareness to a room full of proteomics decision makers.

Join Pharma Experts
Join Biopharma Experts

Be part of cutting-edge discussions with fellow proteomics pioneers to transform drug discovery across a range of modalities, whether you’re working on TPD, ADCs, small molecules, or beyond.